1.Age-specific variations in hematological and biochemical parameters in middle- and large-sized of dogs
Seok Hee LEE ; Jin Wook KIM ; Byeong Chun LEE ; Hyun Ju OH
Journal of Veterinary Science 2020;21(1):7-
Enzyme-linked immunosorbent assay was used to target growth hormone (GH)/insulin growth factor-1 (IGF-1), one of the main regulators of the aging process. Declining levels of total protein and increased levels of glucose in young dogs was observed regardless of their body size. Notably, a significantly high concentration of GH and IGF-1 in the younger dogs compared to the older dogs was found in middle/large-sized dogs. GH and IGF-1 were also found at significantly high levels in large-sized dogs compared to middle-sized dogs, suggesting a similar trend to that of elderly humans. Consequently, glucose, total protein, GH, and IGF-1 were identified as potential biomarkers for regulating the aging process in large/middle-sized dogs. These findings provide an invaluable insight into the mechanism of aging for the field of aging research.]]>
Aged
;
Aging
;
Animals
;
Biomarkers
;
Body Size
;
Dogs
;
Enzyme-Linked Immunosorbent Assay
;
Genomic Instability
;
Glucose
;
Growth Hormone
;
Hematologic Tests
;
Humans
;
Insulin-Like Growth Factor I
;
Mammals
;
Quality of Life
2.Multi-Epitope Fusion Protein Eg mefAg-1 as a Serodiagnostic Candidate for Cystic Echinococcosis in Sheep
Liu TIANLI ; Wang XIFENG ; Tian ZHENZHONG ; Wang LIXIA ; Zhang XINGXING ; Qiao JUN ; Meng QINGLING ; Gong SHASHA ; Chen YING ; Cai XUEPENG
The Korean Journal of Parasitology 2019;57(1):61-67
Cystic echinococcosis (CE) in sheep is a hazardous zoonotic parasitic disease that is caused by Echinococcus granulosus (Eg). At present, serological test is an important diagnostic method for Eg infection in domestic animals. Here, a fusion protein Eg mefAg-1 harboring 8 dominant B-cell epitopes of Eg such as antigen B, tetraspanin 1, tetraspanin 6, reticulon and Eg95 was produced in E. coli and evaluated for CE in sheep by indirect ELISA. Eg mefAg-1 showed in ELISA a high sensitivity (93.41%) and specificity (99.31%), with a coincidence rate of 97.02%. Overall, it is suggested that the Eg mefAg-1 could be a potential antigen candidate for CE serodiagnosis in sheep.
Animals, Domestic
;
Echinococcosis
;
Echinococcus granulosus
;
Enzyme-Linked Immunosorbent Assay
;
Epitopes, B-Lymphocyte
;
Methods
;
Parasitic Diseases
;
Sensitivity and Specificity
;
Serologic Tests
;
Sheep
3.The Performance of the Agility System for Interferon Gamma Release Assay Using QuantiFERON TB Gold In-Tube Assay
Journal of Laboratory Medicine and Quality Assurance 2019;41(1):29-38
BACKGROUND: As stated in ‘The Action Strategy for Tuberculosis-Free Korea,’ last March, high-throughput, large-scale analytical instruments for interferon gamma release assays (IGRA) are demanded by many clinical laboratories using the QuantiFERON-TB Gold In-Tube assay (Cellestis/Qiagen, Australia). Agility (Dynex Technologies, USA) is an automated high-throughput enzyme linked immunosorbent assay analyser. The present study aimed to evaluate its accuracy and speed. METHODS: Pooled plasma was prepared using samples obtained after IGRA testing. Analyses of precision, linearity, cut-off evaluation, and comparison with conventional methods were performed for multiple Agility instruments according to the Clinical and Laboratory Standards Institute EP5-A3, EP6-A, EP9-A3 and EP12-A2 guidelines. The turnaround time and throughput were also analysed. RESULTS: The coefficient of variation range was 2.48%–4.0%, 7.01%–11.17%, and 9.69%–14.84% for the repeatability, between-run precision, and between-day precision analyses, respectively. The linearity ranged from 0 to 10.541. Comparison analysis presented a high concordance of Agility with the conventional instrument, DS2 (Dynex Technologies), and manual method for IGRA. The cut-off value of 0.35 IU/mL was well compatible with the C50. It was identified that the C50±20% contained the C5–C95 interval. The average turnaround time was 3.84 hours, from the submission of pre-treated samples to the reporting of results. The throughput was determined to be 290 tests during a routine working time of 8 hours. CONCLUSIONS: Agility showed high precision, linearity, concordance, and had a 2.5 times faster throughput than with the conventional and manual method. It could be useful for large-scale IGRA testing in latent tuberculosis infection screening project. Samples within C50±20% are suspected to show relatively low reporducible results of high inversion between postivie and negative.
Enzyme-Linked Immunosorbent Assay
;
Interferon-gamma Release Tests
;
Interferons
;
Latent Tuberculosis
;
Mass Screening
;
Methods
;
Plasma
4.Performance Verification of HIV Test in Blood Station Laboratory.
Journal of Experimental Hematology 2019;27(4):1287-1290
OBJECTIVE:
To investigate the methods for verifying and comparing performance of HIV testing methods and procedure analysis in blood station laboratories so as to meet the requirements of ISO15189 accreditation.
METHODS:
The performance of HIV test was verified by the automatic ELISA analyzer, the intra- and inter-assay precision was analyzed and evaluated by intra- and inter-assay repeat tests, the compliance rate was verified by the test results of the standard serum plate and the external quality assessment from the Ministry of Health in the past 2 years, the limit of detection was verified through continuous dilution of a known amount of reference serum for internal quality control, the status of the instrument was evaluated by testing one HIV-negative specimen, one HIV-negative with other positive markers, one strong HIV-positive specimen and two weak HIV-positive specimens.
RESULTS:
The intra- and inter-assay precisions were 5.12% and 16.81% respectively, the compliance rate of the serum plate test was 100%, the compliance of the external quality assessment results was 100%, the limits of detection for HIV was 1.42 NCU/ml, and the consistency of the detection systems was 100%.
CONCLUSION
The analytical performance of the HIV test methods and procedures accords with the requirements of the reagent instructions, the comparison of the test systems meets the verification requirements.
Enzyme-Linked Immunosorbent Assay
;
HIV
;
Mass Screening
;
Quality Control
;
Serologic Tests
5.The Effect of Trigonella foenum-graceum L. (Fenugreek) Towards Collagen Type I Alpha 1 (COL1A1) and Collagen Type III Alpha 1 (COL3A1) on Postmenopausal Woman's Fibroblast
Shannaz Nadia YUSHARYAHYA ; Kusmarinah BRAMONO ; Natalia Rania SUTANTO ; Indra KUSUMA
Natural Product Sciences 2019;25(3):208-214
Trigonella foenum-graceum L. (fenugreek) is a phytoestrogen, a nonsteroidal organic chemical compound from plants which has similar mechanism of action to sex hormone estradiol-17β. This study aims to assess the effectivity of fenugreek seeds extract on collagen type I alpha 1 (COL1A1) and collagen type III alpha 1 (COL3A1) which are both decreased in aging skin and become worsen after menopause. This in vitro experimental study used old human dermal fibroblast from leftover tissue of blepharoplasty on a postmenopausal woman (old HDF). As a control of the fenugreek's ability to trigger collagen production, we used fibroblast from preputium (young HDF). Subsequent to fibroblast isolation and culture, toxicity test was conducted on both old and young HDF by measuring cell viability on fenugreek extract with the concentration of 5 mg/mL to 1.2 µg/mL which will be tested on both HDF to examine COL1A1 and COL3A1 using ELISA, compared to no treatment and 5 nM estradiol. Old HDF showed a 4 times slower proliferation compared to young HDF (p<0.05). Toxicity test revealed fenugreek concentration of 0.5 – 2 µg/mL was non-toxic to both old and young HDF. The most significant fenugreek concentration to increase COL1A1 and COL3A1 secretion was 2 µg/mL (p<0.05).
Aging
;
Blepharoplasty
;
Cell Survival
;
Collagen Type I
;
Collagen Type III
;
Collagen
;
Enzyme-Linked Immunosorbent Assay
;
Estradiol
;
Female
;
Fibroblasts
;
Humans
;
In Vitro Techniques
;
Menopause
;
Phytoestrogens
;
Skin
;
Toxicity Tests
;
Trigonella
6.Comparison of Six Commercial Diagnostic Tests for the Detection of Dengue Virus Non-Structural-1 Antigen and IgM/IgG Antibodies
Hyeyoung LEE ; Ji Hyeong RYU ; Hye Sun PARK ; Ki Hyun PARK ; Hyunjoo BAE ; Sojeong YUN ; Ae Ran CHOI ; Sung Yeon CHO ; Chulmin PARK ; Dong Gun LEE ; Jihyang LIM ; Jehoon LEE ; Seungok LEE ; Soyoung SHIN ; Haeil PARK ; Eun Jee OH
Annals of Laboratory Medicine 2019;39(6):566-571
ELISAs and rapid diagnostic tests (RDTs) are widely used for diagnosing dengue virus (DENV) infection. Using 138 single blood samples, we compared the ability to detect non-structural (NS)-1 antigen and anti-DENV IgM/IgG antibodies among (1) DENV Detect NS1 ELISA, DENV Detect IgM capture ELISA and DENV Detect IgG ELISA (InBios International, Inc.); (2) Anti-Dengue virus IgM Human ELISA and Anti-Dengue virus IgG Human ELISA (Abcam); (3) Dengue virus NS1 ELISA, Anti-Dengue virus ELISA (IgM) and Anti-Dengue virus ELISA (IgG) (Euroimmun); (4) Asan Easy Test Dengue NS1 Ag 100 and Asan Easy Test Dengue IgG/IgM (Asan Pharm); (5) SD BIOLINE Dengue Duo (Standard Diagnostics); and (6) Ichroma Dengue NS1 and Ichroma Dengue IgG/IgM (Boditech Med). For NS1 antigen detection, InBios and Euroimmun showed higher sensitivities (100%) than the RDTs (42.9–64.3%). All tests demonstrated variable sensitivities for IgM (38.1–90.5%) and IgG (65.7–100.0%). InBios and Boditech Med demonstrated higher sensitivity (95.6% and 88.2%, respectively) than the other tests for combined NS1 antigen and IgM antibody. Five NS1 antigen tests had good agreement (92.8–98.6%) without showing positivity for chikungunya. However, all IgG tests demonstrated potential false-positivity with variable ranges. Clinical laboratories should note performance variations across tests and potential cross-reactivity.
Antibodies
;
Chungcheongnam-do
;
Dengue Virus
;
Dengue
;
Diagnosis
;
Diagnostic Tests, Routine
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Immunoglobulin G
;
Immunoglobulin M
7.Effect of simultaneous administration of foot-and-mouth disease (FMD) and anthrax vaccines on antibody response to FMD in sheep
Can ÇOKÇALIŞKAN ; Pelin TUNCER GÖKTUNA ; Tunçer TÜRKOĞLU ; Ergün UZUNLU ; Ceylan GÜNDÜZALP ; Eylem Aras UZUN ; Beyhan SAREYYÜPOĞLU ; Ayça KÜRKÇÜ ; Veli GÜLYAZ
Clinical and Experimental Vaccine Research 2019;8(2):103-109
PURPOSE: Foot-and-mouth disease (FMD) and anthrax are important diseases in sheep. Vaccination is a favorable strategy against both infections. Simultaneous administration of vaccines does generally not impede the immune responses of each other, although there are some exceptions, and it may help reduce the labor and costs of vaccination as well as distress on animals. Although oil adjuvant FMD vaccine has been tried with live anthrax vaccine in cattle, there are no reports on the simultaneous use of both vaccines in sheep. MATERIALS AND METHODS: In this study, FMD seronegative sheep were used to investigate the impact of the simultaneous vaccination of FMD and anthrax on FMD antibody titers of sheep. Virus neutralization test and liquid phase blocking enzyme-linked immunosorbent assay were used to determine the antibody response to the FMD vaccine. RESULTS: The results demonstrated that both vaccines can be used simultaneously without any interference with the FMD response. Moreover, the simultaneous administration with anthrax vaccine had a stimulating effect on the early (day 7 post-vaccination) virus neutralization antibody response to the FMD vaccine. CONCLUSION: The simultaneous use of the FMD and anthrax vaccines did not hinder the response to the FMD vaccine in sheep.
Animals
;
Anthrax Vaccines
;
Anthrax
;
Antibody Formation
;
Cattle
;
Enzyme-Linked Immunosorbent Assay
;
Foot-and-Mouth Disease
;
Neutralization Tests
;
Sheep
;
Vaccination
;
Vaccines
8.Serodiagnosis of Extraintestinal Amebiasis: Retrospective Evaluation of the Diagnostic Performance of the Bordier® ELISA Kit
Nicolas BEYLS ; Odile COGNET ; Jean Paul STAHL ; Olivier ROGEAUX ; Herve PELLOUX
The Korean Journal of Parasitology 2018;56(1):71-74
Soluble antigens from an axenic culture of Entamoeba histolytica were used to develop a commercial ELISA kit to quantify anti-E. histolytica antibodies in sera of patients with extraintestinal amebiasis in non-endemic settings. The diagnostic specificity and sensitivity of the test were assessed retrospectively using 131 human serum samples with amoebic serologic status available. They were selected according to their results in immunofluorescence (IFAT) and were separated in 2 sample categories: 64 sera with positive results by IFAT and 67 with negative results by IFAT. The sensitivity and specificity of the ELISA kit were assessed at 95.0% and 94.0% compared to the IFAT. The test can be useful to exclude a potential diagnosis of amebiasis and could be used as a screening method since ELISA is an automated technique.
Amebiasis
;
Antibodies
;
Axenic Culture
;
Diagnosis
;
Entamoeba histolytica
;
Enzyme-Linked Immunosorbent Assay
;
Fluorescent Antibody Technique
;
Humans
;
Mass Screening
;
Methods
;
Retrospective Studies
;
Sensitivity and Specificity
;
Serologic Tests
9.Development of a Rapid Diagnostic Test Kit to Detect IgG/IgM Antibody against Zika Virus Using Monoclonal Antibodies to the Envelope and Non-structural Protein 1 of the Virus
Yeong Hoon KIM ; Jihoo LEE ; Young Eun KIM ; Chom Kyu CHONG ; Yanaihara PINCHEMEL ; Francis REISDÖRFER ; Joyce Brito COELHO ; Ronaldo Ferreira DIAS ; Pan Kee BAE ; Zuinara Pereira Maia GUSMÃO ; Hye Jin AHN ; Ho Woo NAM
The Korean Journal of Parasitology 2018;56(1):61-70
We developed a Rapid Diagnostic Test (RDT) kit for detecting IgG/IgM antibodies against Zika virus (ZIKV) using monoclonal antibodies to the envelope (E) and non-structural protein 1 (NS1) of ZIKV. These proteins were produced using baculovirus expression vector with Sf9 cells. Monoclonal antibodies J2G7 to NS1 and J5E1 to E protein were selected and conjugated with colloidal gold to produce the Zika IgG/IgM RDT kit (Zika RDT). Comparisons with ELISA, plaque reduction neutralization test (PRNT), and PCR were done to investigate the analytical sensitivity of Zika RDT, which resulted in 100% identical results. Sensitivity and specificity of Zika RDT in a field test was determined using positive and negative samples from Brazil and Korea. The diagnostic accuracy of Zika RDT was fairly high; sensitivity and specificity for IgG was 99.0 and 99.3%, respectively, while for IgM it was 96.7 and 98.7%, respectively. Cross reaction with dengue virus was evaluated using anti-Dengue Mixed Titer Performance Panel (PVD201), in which the Zika RDT showed cross-reactions with DENV in 16.7% and 5.6% in IgG and IgM, respectively. Cross reactions were not observed with West Nile, yellow fever, and hepatitis C virus infected sera. Zika RDT kit is very simple to use, rapid to assay, and very sensitive, and highly specific. Therefore, it would serve as a choice of method for point-of-care diagnosis and large scale surveys of ZIKV infection under clinical or field conditions worldwide in endemic areas.
Antibodies
;
Antibodies, Monoclonal
;
Baculoviridae
;
Brazil
;
Cross Reactions
;
Dengue Virus
;
Diagnosis
;
Diagnostic Tests, Routine
;
Enzyme-Linked Immunosorbent Assay
;
Flavivirus
;
Gold Colloid
;
Hepacivirus
;
Immunoglobulin G
;
Immunoglobulin M
;
Korea
;
Methods
;
Neutralization Tests
;
Point-of-Care Systems
;
Polymerase Chain Reaction
;
Reagent Kits, Diagnostic
;
Sensitivity and Specificity
;
Sf9 Cells
;
Yellow Fever
;
Zika Virus
10.Efficacy of inactivated variant porcine epidemic diarrhea virus vaccines in growing pigs
Seung Heon LEE ; Dong Kun YANG ; Ha Hyun KIM ; In Soo CHO
Clinical and Experimental Vaccine Research 2018;7(1):61-69
PURPOSE: The first aim of this study was to develop a novel inactivated porcine epidemic diarrhea virus (PEDV) vaccine using the recently isolated Korean PEDV QIAP1401 strain and to evaluate its protective efficacy in growing pigs. The second was to determine the optimum adjuvant formulation of the inactivated PEDV vaccine that induces protection against viral challenge. MATERIALS AND METHODS: To generate high titers of infectious PEDV, the QIAP1401 isolate was passaged in Vero cells. The experimental vaccines were prepared from a binary ethyleneimine-inactivated QIAP1401 strain passaged sequentially 70 times (QIAP1401-p70), formulated with four commercial adjuvants, and administered twice intramuscularly to growing pigs. Challenge studies using a virulent homologous strain of PEDV QIAP1401-p11, which was passaged 11 times after isolation, were performed to assess protection against disease progression and viral shedding during the 15-day observation period. The vaccine-induced antibody responses were measured in serum samples collected at predetermined time points by indirect enzyme-linked immunosorbent assay and virus neutralization test. RESULTS: The QIAP1401-p70 strain had 42 amino acid (aa) mutations, including a 25 aa deletion, and was selected as the inactivated PEDV vaccine candidate. Although none of the pigs that received the experimental vaccines were completely protected against subsequent viral challenge, they exhibited a significantly higher immune response than did non-vaccinated control pigs. Among the vaccine groups, the highest antibody responses were observed in the pigs that received an oil-based multiphasic water/oil/water (W/O/W) emulsion adjuvanted vaccine, which delayed the onset of clinical symptoms and viral shedding. CONCLUSION: A novel inactivated PEDV vaccine formulated with a W/O/W emulsion adjuvant was both immunogenic and protective against viral challenge.
Antibody Formation
;
Disease Progression
;
Enzyme-Linked Immunosorbent Assay
;
Neutralization Tests
;
Porcine epidemic diarrhea virus
;
Swine
;
Vaccines
;
Vero Cells
;
Virus Shedding

Result Analysis
Print
Save
E-mail